PMID- 35912246 OWN - NLM STAT- PubMed-not-MEDLINE LR - 20220802 IS - 2234-943X (Print) IS - 2234-943X (Electronic) IS - 2234-943X (Linking) VI - 12 DP - 2022 TI - Pathogens and Pathogenesis in Wheezing Diseases in Children Under 6. PG - 922214 LID - 10.3389/fonc.2022.922214 [doi] LID - 922214 AB - Few studies have comprehensively assessed the roles of cytokine production in wheezing pathogenesis. Therefore, we undertook this study to determine the association between wheezing episodes and cytokines, and to provide further information on this topic. Firstly, we retrospectively collected I176 children, including 122 subjects with first wheezing and 54 subjects with recurrent wheezing, to analyze the etiology and clinical characteristics of children with wheezing diseases. Then, we collected 52 children with wheezing diseases and 25 normal controls to detect the expression of interferon-gamma (IFN-gamma), interleukin-4 (IL-4), IFN-gamma/IL-4, IL-17A, IL-17E, IgE, matrix metalloproteinase-3 (MMP-3), and MMP-9 in serum or plasma. The results showed that boys under 3 years old with history of allergies were more likely to develop wheezing diseases. In our cohort, M. pneumoniae caused a greater proportion of wheezing in children than expected. The expression of IgE [18.80 (13.65-31.00) vs. 17.9 (10.15-21.60)], IL-4 [24.00 (24.00-48.00) vs. 23.00 (9.50-27.00)], IFN-gamma [70.59 (41.63-116.46) vs. 49.83 (29.58-81.74)], MMP3 [53.40 (20.02-128.2) vs. 30.90 (13.80-50.95)], MMP9 [148.10 (99.30-276.10) vs. 122.10 (82.20-162.35)], IL-17A [80.55 (54.46-113.08) vs. 61.11 (29.43-93.87)], and IL-17E [1.75 (0.66-2.77) vs. 1.19 (0.488-2.1615)] were significantly increased in the wheezing group (p<0.05) compared to normal controls, while the level of IFN-gamma/IL-4 had no significant difference between the two groups (1.24 +/- 1.88 vs 0.68 +/- 0.74, p>0.05). There was altered cytokine production in children with wheezing diseases which was quite similar to asthma pathogenesis. Sex, age, pathogen infection, and inflammation in our study were also risk factors for wheezing diseases. CI - Copyright (c) 2022 Tang, Yang, He, Huang, Zheng and Liu. FAU - Tang, Yongjun AU - Tang Y AD - Department of Pediatrics, Xiangya Hospital, Central South University, Changsha, China. FAU - Yang, Yaxiong AU - Yang Y AD - Department of Pediatrics, Xiangya Hospital, Central South University, Changsha, China. FAU - He, Ruohui AU - He R AD - Department of Pharmacy, Ningyuan County of People's Hospital, Yongzhou, China. FAU - Huang, Rong AU - Huang R AD - Department of Pediatrics, Xiangya Hospital, Central South University, Changsha, China. FAU - Zheng, Xiangrong AU - Zheng X AD - Department of Pediatrics, Xiangya Hospital, Central South University, Changsha, China. FAU - Liu, Chentao AU - Liu C AD - Department of Pediatrics, Xiangya Hospital, Central South University, Changsha, China. LA - eng PT - Journal Article DEP - 20220714 PL - Switzerland TA - Front Oncol JT - Frontiers in oncology JID - 101568867 PMC - PMC9329614 OTO - NOTNLM OT - IFN-gamma OT - IL-17 OT - IL-4 OT - IgE OT - MMP OT - infant OT - wheezing COIS- The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. EDAT- 2022/08/02 06:00 MHDA- 2022/08/02 06:01 PMCR- 2022/01/01 CRDT- 2022/08/01 03:58 PHST- 2022/04/17 00:00 [received] PHST- 2022/06/17 00:00 [accepted] PHST- 2022/08/01 03:58 [entrez] PHST- 2022/08/02 06:00 [pubmed] PHST- 2022/08/02 06:01 [medline] PHST- 2022/01/01 00:00 [pmc-release] AID - 10.3389/fonc.2022.922214 [doi] PST - epublish SO - Front Oncol. 2022 Jul 14;12:922214. doi: 10.3389/fonc.2022.922214. eCollection 2022.